Mandate

Vinge advises Intrum in connection with its EUR 450m bond issuance

Vinge advises Intrum AB (publ) in connection with its issuance of senior secured fixed rate bonds in an amount of EUR 450 million.

The proceeds will be used to refinance, in part, Intrum’s 3.125% Senior Notes due 2024, and the bonds will be listed on the Securities Official List of the Luxembourg Stock Exchange. The bonds have a tenor of five years and were issued with a coupon of 9.25 per cent and at a price of 97.020% of the nominal amount.

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda, Jolinn Uhlin, Calle Tengwall Pagels (Banking and Finance), Victor Ericsson and Maja Prahl (Tax)

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024